Friedl-Naderer Johanna sold DYN
March 5, 2026 · Form 4 insider transaction
Friedl-Naderer Johanna sold 148 shares of Dyne Therapeutics, Inc. at $14.90 per share, a transaction worth $2.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on December 4, 2024. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person.; Includes 129,790 unvested RSUs.